Biodelivery Sciences International to participate in investor conferences

Download PDF Copy

Editorial Checklist

Reviewed

Sep 3 2009

BioDelivery Sciences International, Inc. (Nasdaq: BDSI) today announced its participation in the following upcoming investor conferences:

Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences, will present at the Robert W. Baird 2009 Health Care Conference on Wednesday, September 9, 2009 at 2:45 p.m. Eastern Time in New York City.
Dr. Sirgo will also present at the Rodman & Renshaw Annual Global Investment Conference on Thursday, September 10, 2009 at 2:00 p.m. Eastern Time in New York City.
Dr. Andrew L. Finn, BDSI’s Executive Vice President of Product Development, will present at the NewsMakers in the Biotech Industry Conference on Wednesday, September 16, 2009 at 11:00 a.m. Eastern Time in New York City.

Dr. Sirgo and Dr. Finn will be discussing the recent FDA approval and market opportunity for ONSOLIS (fentanyl buccal soluble film) and the status of BDSI’s product pipeline, including BEMA Buprenorphine and Bioral Amphotericin B.

Source:

http://www.biodeliverysciences.com

Posted in:

Tags: Cancer, Drug Delivery, Fentanyl, Health Care, Oncology, Onsolis

Comments (0)

Download PDF Copy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.